Heterocyclic GLP-1 agonists
Summary
USPTO granted patent US12595264B2 to Gasherbrum Bio, Inc. on April 7, 2026, covering heterocyclic GLP-1 receptor agonists of Formula (I), including pharmaceutical salts, solvates, and compositions. The patent names six inventors and contains 24 claims, with CPC classifications spanning heterocyclic chemistry (C07D 487/04), phosphorus compounds (C07F 9/6561), and pharmaceutical formulations (A61K 31/4985, A61K 38/26).
What changed
USPTO issued patent US12595264B2 to Gasherbrum Bio, Inc. for heterocyclic GLP-1 agonists of Formula (I), including pharmaceutical salts, solvates, and compositions. The patent covers 24 claims across heterocyclic chemistry, phosphorus compounds, and pharmaceutical formulations related to GLP-1 receptor modulation.
Pharmaceutical and biotechnology companies developing GLP-1 based therapies for diabetes, obesity, or metabolic disorders should monitor this patent landscape when designing R&D programs, formulation strategies, and licensing arrangements to avoid infringement on Gasherbrum Bio's newly granted IP rights.
What to do next
- Monitor for updates
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Heterocyclic GLP-1 agonists
Grant US12595264B2 Kind: B2 Apr 07, 2026
Assignee
Gasherbrum Bio, Inc.
Inventors
Qinghua Meng, Weiqiang Xing, Haizhen Zhang, Xichen Lin, Hui Lei, Andrew Jennings
Abstract
This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
CPC Classifications
C07D 487/04 C07F 9/6561 A61K 31/155 A61K 31/4985 A61K 31/675 A61K 38/26 C07B 2200/07
Filing Date
2021-09-08
Application No.
18044743
Claims
24
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.